A nanoparticle depot formulation of 4-(N)-stearoyl gemcitabine shows a strong anti-tumour activity

OBJECTIVES: Depot formulation as a carrier for cytotoxic chemotherapeutic drugs is not well studied. The objective of this study is to test the feasibility of using a subcutaneous depot formulation to administer a cytotoxic anti-cancer drug for systemic therapy. METHODS: A fatty-acid amide prodrug o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhu, Saijie, Li, Xinran, Lansakara-P, Dharmika S P, Kumar, Amit, Cui, Zhengrong
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2012
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3539214/
https://ncbi.nlm.nih.gov/pubmed/23278691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.2042-7158.2012.01599.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars